Context - Vaccination saves millions of lives each year. How do they work and is there still progress to be made?
Latest update: 30 September 2014Vaccination is one of the most cost-effective available health interventions, saving more than 3 million lives each year and many million more from illness and disability. Effective and safe vaccines, which protect against more than 20 serious diseases, are currently available and many promising new vaccines are being developed. Vaccinations can provide protection not just for the vaccinated person, but for the population as a whole as well. This phenomenon, called community immunity or herd immunity, occurs when a large portion of the population is vaccinated, usually over 85%, depending on the disease. If global vaccination coverage was to be increased enough to reach 90% of the population, an additional 2 million lives each year could be saved.
In response to an infection, some white blood cells produce antibodies , molecules that help the body react quickly and effectively to the intruding germs. The first time the body encounters a germ, it takes several days to make and use all the germ-fighting tools needed to get over the infection, including the production of antibodies.
After the first infection, the immune system keeps a memory for this germ for years, and when the body encounters the same germ another time, the defense response is both faster and stronger.
Vaccines contribute thus to develop immunity by imitating an infection without causing the illness, and by causing the body to produce the antibodies and the memory against the infectious agents.
The vaccination programmes of most countries include the same basic vaccines for diphtheria, tetanus, pertussis (or whooping cough), measles, polio, and tuberculosis. Over the years additional vaccines have been added. They include vaccines against hepatitis B, Haemophilus influenzae type b, mumps, pneumococcal disease, rotavirus, rubella, and – in countries where needed – yellow fever and Japanese encephalitis.
Among more recent vaccines, significant progress has been achieved in the introduction of Human papilloma-virus (HPV), pneumococcal and rotavirus vaccines in the WHO European Region. Twenty-six countries have recommended or funded use of HPV vaccine (which is the only vaccine that can prevent a cancer) for national immunization programmes.
As once-common diseases become less frequent, fear of the diseases themselves tend to become overshadowed by vaccine safety concerns, sometimes fueled by misinformation about vaccination, says the WHO. Although there are reports of side effects due to vaccinations, few of them are serious, and the risk from getting a disease like diphtheria or polio is much greater than any risk of side effect from vaccines.
The American Center for Disease Control (CDC) has highlighted some misconceptions about vaccination :
According to a UNICEF-WHO-WB report (2009) the first decade of the 21st century has been the most productive in the history of vaccine development. On the one hand, new vaccines are being developed that could reduce illness and deaths, and on the other, new production methods mean that cheaper vaccines can be provided for developing countries. About 30 of these candidates aim to protect against diseases for which there are no vaccines currently available and public-private partnerships are accelerating the availability of these new vaccines. New ways of delivering vaccines are also being developed that do not require an injection, which also facilitates their use.
Vaccination has led to the eradication of smallpox, and poliomyelitis is also almost eradicated. Immunization currently prevents an estimated two to three million deaths every year in all age groups from diphtheria, tetanus, pertussis (whooping cough), and measles. In 2012, an estimated 83% (111 million) of infants worldwide were vaccinated with three doses of Diphtheria-Tetanus-Pertussis (DTP3) vaccine. The total number of children who died from diseases preventable by vaccines currently recommended by WHO is estimated to about 1.5 million.
In Europe, immunization levels are very high. Information to the public is an important part of the strategy of the European WHO regional office to help raise awareness and respond to concerns about vaccine safety.
In South America, it appears that the interruption of endemic measles and rubella virus transmission has been achieved but some countries have reported weakness and failures in their national surveillance systems and routine immunization programs. In the United States in 2012, adult vaccination coverage for diseases other than influenza was still low.
References: |
---|
|
This summary is free and ad-free, as is all of our content. You can help us remain free and independant as well as to develop new ways to communicate science by becoming a Patron!